Female Reproductive System Neoplasm — Trials

Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 251–300 of 1,428 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06107868	Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer(GyneRep)	active not recruiting	Phase 1	6	University Health Network, TorontoOTHER	1	Jun 10, 2026	clinicaltrials
NCT07517198	Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors	recruiting	Phase 1	40	Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.INDUSTRY